LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

NVO

65.43

-3.4%↓

Search

Microbot Medical Inc

Затворен

2.38 -6.3

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.38

Максимум

2.55

Ключови измерители

By Trading Economics

Приходи

-177K

-3.4M

EPS

-0.2

Служители

20

EBITDA

-127K

-3.4M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+252.94% upside

Дивиденти

By Dow Jones

Следващи печалби

20.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

37M

93M

Предишно отваряне

8.68

Предишно затваряне

2.38

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.05.2025 г., 23:20 ч. UTC

Печалби

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13.05.2025 г., 23:48 ч. UTC

Пазарно говорене

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13.05.2025 г., 23:43 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

13.05.2025 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13.05.2025 г., 23:24 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

13.05.2025 г., 23:24 ч. UTC

Пазарно говорене
Печалби

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13.05.2025 г., 22:58 ч. UTC

Печалби

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13.05.2025 г., 22:58 ч. UTC

Печалби

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13.05.2025 г., 22:58 ч. UTC

Печалби

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13.05.2025 г., 22:58 ч. UTC

Печалби

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13.05.2025 г., 22:38 ч. UTC

Печалби

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13.05.2025 г., 22:38 ч. UTC

Печалби

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13.05.2025 г., 22:37 ч. UTC

Печалби

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13.05.2025 г., 22:36 ч. UTC

Печалби

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13.05.2025 г., 22:35 ч. UTC

Печалби

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13.05.2025 г., 22:34 ч. UTC

Печалби

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13.05.2025 г., 22:33 ч. UTC

Печалби

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13.05.2025 г., 22:33 ч. UTC

Печалби

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13.05.2025 г., 22:33 ч. UTC

Печалби

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13.05.2025 г., 22:30 ч. UTC

Печалби

Aristocrat Interim Dividend 44 Australian Cents/Share

13.05.2025 г., 22:30 ч. UTC

Печалби

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13.05.2025 г., 22:29 ч. UTC

Печалби

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13.05.2025 г., 22:28 ч. UTC

Печалби

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13.05.2025 г., 21:15 ч. UTC

Печалби

Nu Holdings 1Q Rev $3.2B >NU

13.05.2025 г., 21:03 ч. UTC

Топ новини

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13.05.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

13.05.2025 г., 20:32 ч. UTC

Печалби

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13.05.2025 г., 20:31 ч. UTC

Печалби

Alcon 1Q Sales $2.45B >ALC.EB

13.05.2025 г., 20:30 ч. UTC

Печалби

Alcon 1Q Rev $2.47B >ALC.EB

13.05.2025 г., 20:30 ч. UTC

Печалби

Alcon 1Q EPS 70c >ALC.EB

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

252.94% нагоре

12-месечна прогноза

Среден 9 USD  252.94%

Висок 9 USD

Нисък 9 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

Краткосрочен план

Neutral Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.